Nisa Investment Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.54K Buy
989
+56
+6% +$223 ﹤0.01% 2529
2025
Q4
$3.27K Sell
933
-700
-43% -$2.4K ﹤0.01% 2527
2025
Q3
$5.32K Buy
1,633
+118
+8% +$372 ﹤0.01% 2426
2025
Q2
$3.71K Buy
1,515
+815
+116% +$4.13K ﹤0.01% 2495
2025
Q1
$4.67K Sell
700
-2,287
-77% -$22.6K ﹤0.01% 2269
2024
Q4
$37.5K Sell
2,987
-63
-2% -$948 ﹤0.01% 1760
2024
Q3
$56.3K Sell
3,050
-110
-3% -$2.25K ﹤0.01% 1621
2024
Q2
$68K Buy
3,160
+764
+32% +$17.5K ﹤0.01% 1575
2024
Q1
$64.5K Buy
2,396
+56
+2% +$1.59K ﹤0.01% 1590
2023
Q4
$70.1K Sell
2,340
-3
-0.1% -$66 ﹤0.01% 1540
2023
Q3
$48K Sell
2,343
-197
-8% -$3.58K ﹤0.01% 1738
2023
Q2
$50.5K Buy
2,540
+550
+28% +$11.1K ﹤0.01% 1745
2023
Q1
$34K Sell
1,990
-141,000
-99% -$2.76M ﹤0.01% 1829
2022
Q4
$2.8M Buy
142,990
+141,000
+7,085% +$2.6M 0.02% 627
2022
Q3
$37K Buy
1,990
+290
+17% +$4.53K ﹤0.01% 1855
2022
Q2
$23K Sell
1,700
-4,500
-73% -$53.6K ﹤0.01% 2014
2022
Q1
$98K Sell
6,200
-1,160
-16% -$20K ﹤0.01% 1621
2021
Q4
$122K Sell
7,360
-140
-2% -$3.82K ﹤0.01% 1443
2021
Q3
$224 Hold
7,500
﹤0.01% 1367
2021
Q2
$332 Sell
7,500
-680
-8% -$29.5K ﹤0.01% 1252
2021
Q1
$363 Buy
8,180
+400
+5% +$22K ﹤0.01% 1264
2020
Q4
$427K Buy
7,780
+980
+14% +$35.7K ﹤0.01% 1218
2020
Q3
$155K Buy
6,800
+1,500
+28% +$37K ﹤0.01% 1397
2020
Q2
$111K Hold
5,300
﹤0.01% 1416
2020
Q1
$74K Hold
5,300
﹤0.01% 1450
2019
Q4
$121K Hold
5,300
﹤0.01% 1405
2019
Q3
$62K Hold
5,300
﹤0.01% 1517
2019
Q2
$80K Hold
5,300
﹤0.01% 1454
2019
Q1
$93K Hold
5,300
﹤0.01% 1444
2018
Q4
$79K Buy
+5,300
New +$88K ﹤0.01% 1392

Other funds holding RCKT